A case for improving pharmaceutical logistics cool-chain
The pharmaceutical industry often talks about improving the pharmaceutical logistics cool-chain performance and efficiency. You then hear the terms ‘partnering’, ‘collaborative working’ and ‘integrated supply chain’. We want to share with you an informative Consultation Paper. Written by Alan Kennedy, it’s called “Medicine or snake oil? – A case for reform of the pharmaceutical logistics cool-chain”. It presents the case for genuine team-work in this segment of the industry. The discussion paper debates the needs for reform in pharmaceutical logistics practice and explores the need for new relationships between stakeholders.
Week 3: The benefits of an integrated pharma-logistics chain
What are the benefits?
The potential payback from using Integrated Logistics Networks (ILN) is strongly publicised in some industries. For example, in the UK construction industry cost savings of more than 30% have been claimed as achievable against implementation costs of just 1%.
Why integration is NOT the norm?
We have described a wealth of potential benefits from the adoption of an Integrated Pharma Logistics Network (IPLN) based around collaborative working. However, that is not to say that integration is without risk or costs to the participants.
Week 4 Coming Soon – Ten steps to a blueprint for action!
Please remember AmSafe Bridport can help in improving pharmaceutical logistics cool-chain. It offers a range of thermal cover solutions from single use covers to a re-usable thermal blanket. All its thermal blankets and covers meet aviation flammability requirements in accordance to FAR/JAR/CS25.853(a).Please click here for more information. Alternatively visit our contact page.